Why the study?
Are patients treated with ziprasidone receiving timely electrocardiographic monitoring for QT prolongation?
Population
4,789 outpatients treated with ziprasidone identified from Taiwan's National Health Insurance Research…
Design
Cohort
Authors
Loading...
ECG monitoring for QT prolongation with ziprasidone is infrequent in practice; leaves open whether interventions improve adherence or reduce risk.
Are patients treated with ziprasidone receiving timely electrocardiographic monitoring for QT prolongation?
Real-world claims data demonstrate significantly underutilized baseline and follow-up ECG monitoring for QT prolongation in patients prescribed ziprasidone.
Lin et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: